Nvidia Gains from AI Partnership, Biohaven Shares Drop After Study Findings

December 26, 2025 - 23:18

In the premarket trading session, shares of Nvidia experienced a modest increase following the announcement of a licensing agreement with the artificial intelligence startup Groq. This partnership is expected to bolster Nvidia's position in the rapidly growing AI sector, reflecting investor confidence in the company's strategic direction.

Conversely, shares of Indian technology services provider Coforge Ltd. faced a decline ahead of the US market opening. This drop comes after the company revealed plans to acquire Encora for an enterprise value of $2.35 billion in an all-stock transaction. Investors are likely weighing the implications of this significant investment on Coforge's future performance.

Meanwhile, Biohaven Pharmaceuticals saw its shares plummet by as much as 14 percent in premarket trading. This decline followed disappointing results from a mid-stage study of its experimental drug BHV-7000, which aimed to treat major depressive disorder. The drug failed to meet its primary endpoint, although some positive trends were noted in specific subgroups of participants, raising questions about the drug's overall efficacy.